Subscribe To
Is regeneron stock a buy now?
Regeneron's latest regulatory approval comes at an opportune time. The company's current lineup should continue generating growing sales....
August 25, 2023, 10:15 am
Is baidu stock a buy now?
Baidu's Q2 numbers easily beat analysts' expectations. Its revenue growth is accelerating and its margins are expanding....
August 25, 2023, 9:53 am
Is palo alto networks stock a buy now?
Palo Alto Networks is trading at a rich valuation following its hot rally. Yet, the company is rolling out plenty of products to sustain solid growth....
August 25, 2023, 9:30 am
Is snowflake stock a buy?
Snowflake's Q2 earnings easily beat analysts' expectations. Its growth is cooling off, but it's still on track to hit its fiscal 2029 targets....
August 25, 2023, 6:12 am
Is agree realty a buy?
Agree Realty is a triple-net lease REIT with a defensive investment profile. It's a good investment for an income investor....
August 25, 2023, 6:03 am
Up 100% this year, is tesla stock still a buy?
Tesla is well positioned to survive EV industry price wars. Despite its high price tag, Tesla's valuation is still reasonable, considering its long-te...
August 25, 2023, 5:46 am
Keyera: dividend hike finally comes through for this 6% yielding stock (rating downgrade)
Keyera's Q2 2023 earnings were excellent, with adjusted funds from operations exceeding consensus estimates. The company raised its guidance for the y...
August 24, 2023, 5:24 pm
Tyson foods is still a buy
I analyzed Tyson Foods a year ago, and rated it a buy in what was an apparent mistake. I am revisiting ...
August 24, 2023, 3:39 pm
Why canoo stock is still sinking
Alliance Global Partners issued a buy rating for Canoo stock today. Alliance Global thinks Canoo stock ...
August 24, 2023, 1:46 pm
Is trending stock gms inc. (gms) a buy now?
GMS (GMS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock'...
August 24, 2023, 10:31 am
Zentalis: a buy as small molecule trials continue to advance
Zentalis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing targeted cancer therapies. The company's financials show ...
August 24, 2023, 9:42 am
Travelzoo: recent selloff offers a buy the dip opportunity
Travelzoo is having a strong year with solid growth and climbing profitability. The company is benefiting from momentum in its European segment and th...
August 24, 2023, 7:40 am
Is zoom stock a buy?
Zoom's growth is all coming from its enterprise sales. Cash flow is strong, pointing to better annual earnings ahead....
August 24, 2023, 7:19 am
Brookfield asset management: if i could own just one company this would be it
Brookfield Asset Management is a top pick for a buy-and-hold forever stock due to its strong growth pot...
August 24, 2023, 7:15 am
Northern oil and gas: a buy until the music stops, again
Northern Oil and Gas is an oil and gas company with a unique business model that is heavily reinvesting cash flows that could benefit it if oil prices...
August 24, 2023, 6:29 am
F.n.b. corporation: solid asset base brings a buy case
F.N.B. Corporation has proven its capacity to grow quickly and deliver a sound return to shareholders, with a current yield of over 4% and a low P/E r...
August 24, 2023, 3:57 am
Deere & company: solid q3 results justify a buy rating
Deere & Company reported strong sales growth and exceptional cost control in the third quarter of 2023. The company's "Production and Precision Ag" se...
August 24, 2023, 3:21 am
Near 7% dividend yield at bank of nova scotia, a buy opportunity
Bank of Nova Scotia was rated Buy today, more bullish than the consensus from analysts and the quant system. Positives: near 7% dividend yield, valuat...
August 23, 2023, 11:41 pm
Foot locker shares crumble amid "consumer softness." is this a buying opportunity?
Foot Locker missed Wall Street's sales and earnings expectations in Q2. The company also suspended its dividend and cut full-year guidance again....
August 23, 2023, 4:32 pm
Abbvie: still a buy according to buffett's 10xebt rule
AbbVie investors have good reason to be concerned about the company's future return potential. Sales are expected to fall markedly this year due to th...
August 23, 2023, 4:06 pm